There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on CVRx (CVRX – Research Report) and DocGo (DCGO – Research Report) with bullish sentiments.
CVRx (CVRX)
Canaccord Genuity analyst William Plovanic maintained a Buy rating on CVRx yesterday and set a price target of $32.00. The company’s shares closed last Wednesday at $25.12.
According to TipRanks.com, Plovanic is a 1-star analyst with an average return of
CVRx has an analyst consensus of Strong Buy, with a price target consensus of $34.00, which is a 32.7% upside from current levels. In a report issued on January 26, J.P. Morgan also maintained a Buy rating on the stock with a $36.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
DocGo (DCGO)
Canaccord Genuity analyst Richard Close maintained a Buy rating on DocGo yesterday and set a price target of $11.00. The company’s shares closed last Wednesday at $3.70, close to its 52-week low of $2.78.
According to TipRanks.com, Close is a 5-star analyst with an average return of
DocGo has an analyst consensus of Strong Buy, with a price target consensus of $12.00, a 225.2% upside from current levels. In a report issued on January 16, Northland Securities also maintained a Buy rating on the stock with a $12.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on CVRX:
